Dec 6, 2022
Aronora Inc., a clinical-stage biotechnology company developing next-generation therapeutics for blood clotting diseases, announced today that clinical data from a phase 2 study of Gruticibart will be presented at the 64th American Society of Hematology (ASH) Annual Meeting, taking place in New Orleans, Dec. 10-13, 2022.
Gruticibart (AB023) is a unique recombinant antibody that targets coagulation factor XI (FXI) and specifically inhibits FXI activation by factor XII without blocking its activation by thrombin. It has been specifically designed to treat and prevent blood clots without causing an increased bleeding risk. This phase 2 study evaluated the safety and efficacy of Gruticibart for the prevention of catheter-associated thrombosis in patients with cancer receiving chemotherapy. Additional information about the trial can be found at https://clinicaltrials.gov/ct2/show/NCT04465760.
Details of the oral presentation are as follows:
Title: Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Cancer Patients Undergoing Central Line Placement: A Phase 2 Clinical Trial
Publication Number: 518
Session: 332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Cancer-associated Thrombosis: Risk Stratification, Prevention, and Treatment
Session Date: Sunday, Dec. 11, 2022
Session Time: 12-1:30 p.m.
Presentation Time: 12:15 p.m.
Abstracts are available via the ASH meeting website at https://www.hematology.org/meetings/annual-meeting/abstracts.
Preclinical and early clinical development has been partially supported by the National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) under award numbers R44HL106919, R44HL128016, and R44AI088937. This content is solely the responsibility of Aronora and does not necessarily represent the official views of the NIH.
For more information, please visit www.aronorabio.com.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.
She was stripped of the right to make decisions about her own body and left feeling 'exploited, used and abandoned'.
An unidentified 45-year-old grandfather killed nine of his family members in a horrifying mass shooting on Friday evening in Erie, Pennsylvania.
A teenager is facing a string of charges after allegedly striking a woman with a stolen car while driving erratically through a major city centre.
In a new soft justice scandal, the Ministry of Justice will hide how many prisoners are let out of jail under its controversial new measures.
The decision by the consulting giant came after an internal review sparked by Chris Bradley’s LinkedIn back-and-forth with an author of a new book.
Under the biggest shake-up of road tax laws for decades, officers and transport officials will be responsible for cracking down on anyone suspected of 'odometer fraud'.
Marshall's team asked for 150 custom sugar cookies with Marshall's campaign logo drawn on them, 100 cupcakes, and 100 brownies for his primary election watch party in 2020.
The Conservative leader of the opposition said she saw one victim committing the crime before being beaten to death and the other person 'just being killed'.
A teenager has been charged after a woman was hit by a car near Flinders Street in the middle of Melbourne.
Two teenagers have been charged with murder after a man died in a stabbing in Sydney's west on Friday.
Steve Smith takes three brilliant catches in Australia's first Test against South Africa.
The former Prime Minister hosted three days of festivities including two boozy dinners for more than 100 friends at his Cornish holiday home.